prognostic analysis of non-small cell lung cancer patients with pathological stage II-IIIB

prognostic analysis of non-small cell lung cancer patients with pathological stage II-IIIB - prognostic analysis of non-small cell lung cancer patients with pathological stage II-IIIB

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042893

Enrollment

500

Registered

2021-01-05

Start date

2021-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who underwent surgery for non-small cell lung cancer between 2010 and 2020, patients with pathological stage II-IIIB requiring postoperative adjuvant chemotherapy as standard treatment will be included.

Exclusion criteria

Exclusion criteria: Non-complete resection cases

Design outcomes

Primary

Measure	Time frame
Overall survival by postoperative adjuvant therapy	—

Countries

Japan

Contacts

Public ContactShota Nakamura

Nagoya University Graduate School of Medicine, Department of Thoracic Surgery

shota197065@med.nagoya-u.ac.jp0527442375

Outcome results